Chengjun Mo

842 total citations
27 papers, 646 citations indexed

About

Chengjun Mo is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Chengjun Mo has authored 27 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Chengjun Mo's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Herpesvirus Infections and Treatments (9 papers) and Dysphagia Assessment and Management (4 papers). Chengjun Mo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Herpesvirus Infections and Treatments (9 papers) and Dysphagia Assessment and Management (4 papers). Chengjun Mo collaborates with scholars based in China and United States. Chengjun Mo's co-authors include Ann M. Arvin, Yiwei Qian, Xiaodong Yang, Shaoqing Xu, Marvin Sommer, Xiaoqin He, Qin Xiao, Penghui Ai, Yi Zhang and Eveline E. Schneeberger and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Journal of Virology.

In The Last Decade

Chengjun Mo

26 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengjun Mo China 17 305 213 154 95 84 27 646
Rie Hasebe Japan 17 166 0.5× 454 2.1× 196 1.3× 144 1.5× 103 1.2× 52 1.2k
Jinliang Wang China 17 337 1.1× 251 1.2× 32 0.2× 112 1.2× 17 0.2× 54 941
Chiara Riva Italy 24 264 0.9× 154 0.7× 159 1.0× 233 2.5× 78 0.9× 43 1.3k
Alexsia Richards United States 14 400 1.3× 259 1.2× 61 0.4× 102 1.1× 17 0.2× 22 785
Joseph M. Palmquist United States 9 349 1.1× 113 0.5× 25 0.2× 274 2.9× 47 0.6× 9 649
John N. Davis United States 11 109 0.4× 173 0.8× 81 0.5× 33 0.3× 45 0.5× 15 477
Wenhui Fan China 17 213 0.7× 335 1.6× 34 0.2× 208 2.2× 47 0.6× 58 809
Irena Živković Serbia 18 101 0.3× 255 1.2× 47 0.3× 204 2.1× 72 0.9× 64 778
Judy Chen United States 16 115 0.4× 234 1.1× 108 0.7× 97 1.0× 42 0.5× 36 838
Graciela Cárdenas Mexico 19 106 0.3× 126 0.6× 69 0.4× 142 1.5× 41 0.5× 57 927

Countries citing papers authored by Chengjun Mo

Since Specialization
Citations

This map shows the geographic impact of Chengjun Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengjun Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengjun Mo more than expected).

Fields of papers citing papers by Chengjun Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengjun Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengjun Mo. The network helps show where Chengjun Mo may publish in the future.

Co-authorship network of co-authors of Chengjun Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Chengjun Mo. A scholar is included among the top collaborators of Chengjun Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengjun Mo. Chengjun Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiaoqin, et al.. (2025). Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 12. 100333–100333. 1 indexed citations
2.
Mo, Chengjun, et al.. (2025). Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease. Gut Microbes. 17(1). 2454937–2454937. 3 indexed citations
3.
Zhang, Yi, Shaoqing Xu, Yiwei Qian, et al.. (2023). Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota. Frontiers in Aging Neuroscience. 15. 1099018–1099018. 33 indexed citations
4.
Yang, Xiaodong, Xiaoqin He, Shaoqing Xu, et al.. (2023). Effect of Lacticaseibacillus paracasei strain Shirota supplementation on clinical responses and gut microbiome in Parkinson's disease. Food & Function. 14(15). 6828–6839. 46 indexed citations
5.
He, Xiaoqin, Yiwei Qian, Shaoqing Xu, et al.. (2022). Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson’s disease. npj Parkinson s Disease. 8(1). 48–48. 46 indexed citations
6.
He, Xiaoqin, Chengjun Mo, Yi Zhang, et al.. (2022). Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test. Frontiers in Aging Neuroscience. 13. 778856–778856. 5 indexed citations
7.
8.
Zhang, Yi, Xiaoqin He, Chengjun Mo, et al.. (2022). Association Between Microbial Tyrosine Decarboxylase Gene and Levodopa Responsiveness in Patients With Parkinson Disease. Neurology. 99(22). e2443–e2453. 36 indexed citations
9.
Qian, Yiwei, Yi Zhang, Xiaoqin He, et al.. (2021). Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study. Frontiers in Psychiatry. 12. 615743–615743. 5 indexed citations
10.
Yang, Xiaodong, Yi Zhang, Yimeng Chen, et al.. (2021). LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1α expression. Journal of Neuroinflammation. 18(1). 197–197. 29 indexed citations
11.
Zhang, Yi, Shaoqing Xu, Yiwei Qian, et al.. (2021). Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1α expression in PC12 cells. Brain Research. 1776. 147749–147749. 28 indexed citations
12.
Cai, Mingsheng, Shibo Jiang, Chengjun Mo, et al.. (2015). Preparation and identification of an antiserum against recombinant UL31 protein of pseudorabies virus. Acta Virologica. 59(3). 295–299. 8 indexed citations
13.
14.
Prichard, Mark N., Heather Lawlor, Gregory Duke, et al.. (2005). Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virology Journal. 2(1). 55–55. 44 indexed citations
15.
Wang, Zhaoti, Chengjun Mo, George Kemble, & Gregory Duke. (2004). Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein. Journal of Virological Methods. 120(2). 207–215. 17 indexed citations
16.
Mo, Chengjun, Jay Lee, Marvin Sommer, & Ann M. Arvin. (2003). Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface of melanoma cells. Journal of Medical Virology. 70(S1). S56–S58. 1 indexed citations
17.
Mo, Chengjun, Lee Jc, Marvin Sommer, Charles Grose, & Ann M. Arvin. (2002). The Requirement of Varicella Zoster Virus Glycoprotein E (gE) for Viral Replication and Effects of Glycoprotein I on gE in Melanoma Cells. Virology. 304(2). 176–186. 58 indexed citations
18.
Mo, Chengjun, Eveline E. Schneeberger, & Ann M. Arvin. (2000). Glycoprotein E of Varicella-Zoster Virus Enhances Cell-Cell Contact in Polarized Epithelial Cells. Journal of Virology. 74(23). 11377–11387. 41 indexed citations
19.
Mo, Chengjun, et al.. (1999). Characterization of Varicella-Zoster Virus Glycoprotein K (Open Reading Frame 5) and Its Role in Virus Growth. Journal of Virology. 73(5). 4197–4207. 44 indexed citations
20.
Mo, Chengjun & T C Holland. (1997). Determination of the Transmembrane Topology of Herpes Simplex Virus Type 1 Glycoprotein K (gK). Journal of Biological Chemistry. 272(52). 33305–33311. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rie Hasebe Breakdown of academic impact, for papers by Jinliang Wang Breakdown of academic impact, for papers by Chiara Riva Breakdown of academic impact, for papers by Alexsia Richards Breakdown of academic impact, for papers by Joseph M. Palmquist Breakdown of academic impact, for papers by John N. Davis Breakdown of academic impact, for papers by Wenhui Fan Breakdown of academic impact, for papers by Irena Živković Breakdown of academic impact, for papers by Judy Chen Breakdown of academic impact, for papers by Graciela Cárdenas
Rankless by CCL
2026